TLDR Hsa-miR-193a-5p is important in alopecia areata by promoting inflammation and involving specific genes in hair and immune function.
The correction to the study on hsa-miR-193a-5p in alopecia areata (AA) addresses previous methodological concerns and reinforces the role of hsa-miR-193a-5p in autoimmune conditions by promoting proinflammatory cytokines. It also highlights the involvement of genes such as SLC7A1, SRSF10, TNFRSF19, IPPK, and ZMYM4 in hair follicle biology and immune regulation, emphasizing their relevance in AA. The correction includes detailed methodological information to enhance the study's credibility.
February 2024 in “Scientific reports” Four genes are potential markers for hair loss condition alopecia areata, linked to a specific type of cell death.
Problems with arginine processing in hair follicles might contribute to common hair loss, and arginine supplements could help treat it.
4 citations
,
June 2021 in “Frontiers in Pharmacology” Bone marrow stem cells and their medium help hair regrowth.
15 citations
,
April 2019 in “Journal of Cellular Biochemistry” Certain blood miRNAs are linked to severe alopecia areata and could lead to new treatments.
9 citations
,
February 2019 in “BMC cancer” M30 is a promising treatment for preventing hair loss during chemotherapy.
52 citations
,
October 2012 in “Journal of Dermatological Science” The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.
421 citations
,
April 2012 in “The New England Journal of Medicine” Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.
